These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4480354)

  • 1. [The toxicology of the combination drug dilazep/beta-acetyldigoxin].
    Abel VH; Brock N; Pohl J; Zechel HJ
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1914-20. PubMed ID: 4480354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxicology of dilazep, a new coronary active agent].
    Abel HH; Brock N; Lenke D
    Arzneimittelforschung; 1972 Apr; 22(4):667-74. PubMed ID: 5068245
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract]   [Full Text] [Related]  

  • 5. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the bioavailability of the individual components from a combination of dilazep and beta-acetyldigoxin (author's transl)].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1976; 26(12):2208-13. PubMed ID: 1037278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical factors influencing LD50. I. Viscosity.
    Ritschel WA; Siegel EG; Ring PE
    Arzneimittelforschung; 1974 Jun; 24(6):907-10. PubMed ID: 4408167
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxicity of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine in animal experiment].
    Schultes E; Popendiker K; Doerr BI; Leuschner F
    Arzneimittelforschung; 1971 Oct; 21(10):1446-53. PubMed ID: 5171858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the cumulative properties of solasodine].
    Shashkina LF; Ryndina SE; Starkov MV; Grebennik LI; Kurilenko RP
    Farmakol Toksikol; 1974; 37(6):719-22. PubMed ID: 4464106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
    Pollter J; Schnitker J
    Med Welt; 1976 Oct; 27(43):2074-9. PubMed ID: 792623
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isotope technics in studies on dilazep pharmacokinetics and metabolism in the rat].
    Schaumlöffel E; Clausnitzer M
    Arzneimittelforschung; 1972 Oct; 22(10):1643-50. PubMed ID: 4677051
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isotope technics in studies on dilazep pharmacokinetics and metabolism in man].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1972 Oct; 22(10):1651-5. PubMed ID: 4677052
    [No Abstract]   [Full Text] [Related]  

  • 14. [The validation of the maximum permissible concentration of pyromellitic dianhydride in the atmosphere].
    Sokolov SM; Filonov VP; Amvros'ev PA; Drobenia VV
    Gig Sanit; 1997; (2):6-8. PubMed ID: 9190347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parameters of the acute toxicity and cumulative properties of kanamycin].
    Zel'tser IZ; Lysenko TSh; Shtegel'man LA
    Antibiotiki; 1974 Jun; 19(6):552-6. PubMed ID: 4849342
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxicological and teratological study of a hypocholesterolemiant (MG. 46)].
    Da Lage C; Labie C; Loiseau G; Lohier P; Marquet JP; Truchaud M
    Eur J Toxicol; 1972; 5(4):239-53. PubMed ID: 4649399
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental studies in animals on the toxicity of fominoben-HCl].
    Pappritz G; Bauer M; Serbedija R; Ueberberg H
    Arzneimittelforschung; 1974 Nov; 24(11):1816-21. PubMed ID: 4480056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicological characteristics of the Soviet antidepressant pyrazidol].
    Verstakova OL; Gerchikov LN; Sharova SA; Liberman SS
    Farmakol Toksikol; 1985; 48(1):57-60. PubMed ID: 3979539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.